Patient Guide: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 117 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05092360
Status: TERMINATED
Condition: Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 117 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Anchorage, Alaska
  • Tucson, Arizona
  • • And 114 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily